Is VBIO or RYLD a better dividend investment in 2026?

VBIO currently yields 512.82% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: VBIO offers higher current income.

What is the dividend yield difference between VBIO and RYLD?

VBIO has a forward dividend yield of 512.82% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 500.68 percentage points.

Home › Compare › VBIO vs RYLD

VBIO vs RYLD: Dividend Comparison 2026

VBIO yields 512.82% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 VBIO wins by $74719.33M in total portfolio value

INVESTMENT

TIME HORIZON10 years

VBIO

● Live price

512.82%

Share price

$0.39

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$74719.37M

Annual income

$54,003,807,702.14

Full VBIO calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — VBIO vs RYLD

📍 VBIO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	VBIO	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, VBIO + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

VBIO pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VBIO

Annual income on $10K today (after 15% tax)

$43,589.74/yr

After 10yr DRIP, annual income (after tax)

$45,903,236,546.82/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, VBIO beats the other by $45,903,234,347.57/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VBIO + RYLD for your $10,000?

VBIO: 50%RYLD: 50%

100% RYLD50/50100% VBIO

Portfolio after 10yr

$37359.71M

Annual income

$27,001,905,144.74/yr

Blended yield

72.28%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VBIO buys

RYLD buys

No recent congressional trades found for VBIO or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricVBIORYLD

Forward yield	512.82% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$74719.37M ✓	$44.5K
Annual income after 10y	$54,003,807,702.14 ✓	$2,587.35
Total dividends collected	$72929.43M ✓	$18.8K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: VBIO vs RYLD ($10,000, DRIP)

Year	VBIO Portfolio	VBIO Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$61,982	$51,282.05	$11,914	$1,213.65	+$50.1K → VBIO
2	$363,383	$297,062.31	$14,099	$1,351.30	+$349.3K → VBIO
3	$2,016,476	$1,627,655.79	$16,580	$1,494.55	+$2.00M → VBIO
4	$10,598,885	$8,441,255.59	$19,384	$1,642.61	+$10.58M → VBIO
5	$52,806,644	$41,465,837.52	$22,535	$1,794.70	+$52.78M → VBIO
6	$249,582,121	$193,079,012.24	$26,063	$1,950.00	+$249.56M → VBIO
7	$1,119,909,823	$852,856,952.70	$29,995	$2,107.69	+$1119.88M → VBIO
8	$4,774,834,551	$3,576,531,040.71	$34,361	$2,266.99	+$4774.80M → VBIO
9	$19,360,340,566	$14,251,267,596.86	$39,194	$2,427.12	+$19360.30M → VBIO
10	$74,719,372,108	$54,003,807,702.14	$44,525	$2,587.35	+$74719.33M → VBIO

VBIO vs RYLD: Complete Analysis 2026

VBIO — Stock

Vitality Biopharma, Inc. engages in the development of cannabinoid pharmaceuticals for the treatment of inflammatory disorders in the United States. The company is developing tetrahydrocannabinol glycoside (VBX-100), an oral cannabinoid prodrug for inflammatory bowel disease and irritable bowel syndromes. The company was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016. Vitality Biopharma, Inc. was founded in 2007 and is headquartered in Los Angeles, California.

Full VBIO Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this VBIO vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VBIO vs SCHD VBIO vs JEPI VBIO vs O VBIO vs KO VBIO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.